We are live on ! Find out more
PAVMW

PAVmed Inc. Warrant
PAVMW

Delisted

PAVMW was delisted on the 28th of January, 2022.

Back to rankings

0 hedge funds and large institutions have $0 invested in PAVmed Inc. Warrant in 2018 Q2 according to their latest regulatory filings, with funds opening new positions, increasing their positions, 0 reducing their positions, and 2 closing their positions.

New
Increased
Maintained
Reduced
Closed

100% less funds holding

Funds holding: 2 → 0 (-2)

100% less capital invested

Capital invested by funds: $16K → $0 (-$16K)

100% less first-time investments, than exits

New positions opened: 0 | Existing positions closed: 2

Holders
–
Holders Change
-2
Holders Change %
-100%
% of All Funds
–
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
–
Increased
–
Reduced
–
Closed
2
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

No buyers this quarter

Top Sellers

Rank Fund Capital Flow
1
LCS
Levin Capital Strategies
New York
-$16K
Name Holding Trade Value Shares
Change 		Change in
Stake
LCS
1
Levin Capital Strategies
New York
– -$16K -36,871 Closed

PAVMW Hedge Fund Activity: Q2 2018 in Review

0 of the 4,369 institutional investors tracked by Wall St. Rank reported a position in PAVmed Inc. Warrant (PAVMW) for Q2 2018, worth a combined $0 — down 100% from $16K a quarter earlier.

Sellers outnumbered buyers: 2 funds closed out of PAVMW and 0 opened new positions — a net loss of 2 holders — while 0 trimmed existing stakes and 0 added.

The largest seller was Levin Capital Strategies, exiting entirely with an estimated $16K sold.

  • 0 institutional investors held PAVmed Inc. Warrant (PAVMW) as of Q2 2018, down from 2 in Q1 2018.
  • Funds reported $0 of PAVmed Inc. Warrant stock for Q2 2018, down 100% quarter-over-quarter.
  • 0 funds opened new PAVmed Inc. Warrant positions in Q2 2018 and 2 closed out, a net change of -2 holders.
  • The largest PAVmed Inc. Warrant seller in Q2 2018 was Levin Capital Strategies, an estimated $16K sold.

Based on aggregated 13F filings for Q2 2018.